Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Volume 28, Issue 3, September 2020

Column

ECRI Strategies
10/06/2020

Victor Lane Rose, MBA, NHA, FCPP, CPASRM—Column Editor

Victor Lane Rose, MBA, NHA, FCPP, CPA...
Every competent adult—or his or her representative—has the fundamental right to make informed decisions regarding health care, whether that means declining treatment of terminal illnesses or simply choosing not to follow doctors’ orders.
Every competent adult—or his or her representative—has the fundamental right to make informed decisions regarding health care, whether that means declining treatment of terminal illnesses or simply choosing not to follow doctors’ orders.
Every competent adult—or his or...
10/06/2020
Annals of Long-Term Care
AGS Viewpoint
10/06/2020

American Geriatrics Society (AGS)

American Geriatrics Society (AGS) ...
The American Geriatrics Society (AGS) this summer expressed concern that the new process for sharing COVID-19 data risks fragile progress in our hard-fought national response to the pandemic.
The American Geriatrics Society (AGS) this summer expressed concern that the new process for sharing COVID-19 data risks fragile progress in our hard-fought national response to the pandemic.
The American Geriatrics Society...
10/06/2020
Annals of Long-Term Care

Feature

Review
08/27/2020

Daniel P. Schneider, MD1; Richard G. Stefanacci, DO, MGH, MBA, CMD2; Manju T. Beier, PharmD, BCGP3; Barbara Resnick, PhD, GNP-BC4; Gary W. Small, MD5; Ilene Warner-Maron, PhD, RN, NHA6

Daniel P. Schneider, MD1; Richard G. ...
The 2019 American Geriatrics Society Beers Panel recommendations are to generally avoid all antipsychotic medications in older patients with PD, with exceptions made for quetiapine, clozapine, and pimavanserin. When these agents are used, the...
The 2019 American Geriatrics Society Beers Panel recommendations are to generally avoid all antipsychotic medications in older patients with PD, with exceptions made for quetiapine, clozapine, and pimavanserin. When these agents are used, the...
The 2019 American Geriatrics...
08/27/2020
Annals of Long-Term Care
Clinical Experience
01/13/2020
Eric A Coleman, MD, MPH
Nancy A Whitelaw, PhD
The primary purpose of this article is to illustrate how leadership development can facilitate adoption of evidence-based care and to extract the key lessons to more broadly inform widespread efforts to enhance health care leadership...
The primary purpose of this article is to illustrate how leadership development can facilitate adoption of evidence-based care and to extract the key lessons to more broadly inform widespread efforts to enhance health care leadership...
The primary purpose of this...
01/13/2020
Annals of Long-Term Care
Case Report and Brief Review
12/23/2019

Jonathan T Stewart, MD, DLFAPA, AGSF1,2 • Julie M King, PharmD1 • Danny W Jennings, Jr, OTR/L1 • Lara C Lacassin, PT, DPT1

Jonathan T Stewart, MD, DLFAPA, AGSF1...
Movement disorders after stroke are unusual, seen in between 1% and 4% of patients, but can significantly worsen disability. We report a patient whose disabling post-stroke hemichorea responded well to tetrabenazine, a selective vesicular...
Movement disorders after stroke are unusual, seen in between 1% and 4% of patients, but can significantly worsen disability. We report a patient whose disabling post-stroke hemichorea responded well to tetrabenazine, a selective vesicular...
Movement disorders after stroke...
12/23/2019
Annals of Long-Term Care

Advertisement

Advertisement